Work Package 2 - Outcome Driven Healthcare - is led by Dalia Dawoud, Associate Director (Research), Science, Policy and Research Programme at the National Institute for Health and Care Excellence (NICE); and Hannah Goovaerts, Health Economics & Real-World Manager at Pfizer.
WP2 enables the transition towards outcomes-driven healthcare systems in Europe. This can only be achieved if the EHDEN framework can be used in the context of regulatory approval, health technology assessment (HTA), and for payer purposes. As the EHDEN project is using the OMOP CDM to build a federated network of data sources standardised to a common data model, WP2 tests whether the OMOP CDM can be used for said regulatory, HTA and payer activities.